Evidence map›Paper›PMID 25120537›Full record

ArticleFrontiers in microbiology2014

Identification of a cyclic-di-GMP-modulating response regulator that impacts biofilm formation in a model sulfate reducing bacterium.

Lara Rajeev, Eric G Luning, Sara Altenburg, Grant M Zane, Edward E K Baidoo, Michela Catena, Jay D Keasling, Judy D Wall, Matthew W Fields, Aindrila Mukhopadhyay

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Lara RajeevPhysical Biosciences Division, Lawrence Berkeley National Laboratory Berkeley, CA, USA.
Eric G LuningPhysical Biosciences Division, Lawrence Berkeley National Laboratory Berkeley, CA, USA.
Sara AltenburgCenter for Biofilm Engineering, Montana State University Bozeman, MT, USA.
Grant M ZaneDepartment of Biochemistry, University of Missouri Columbia, MO, USA.
Edward E K BaidooPhysical Biosciences Division, Lawrence Berkeley National Laboratory Berkeley, CA, USA.
Michela CatenaPhysical Biosciences Division, Lawrence Berkeley National Laboratory Berkeley, CA, USA.
Jay D KeaslingPhysical Biosciences Division, Lawrence Berkeley National Laboratory Berkeley, CA, USA ; Department of Chemical and Biomolecular Engineering, Department of Bioengineering, University of California Berkeley, CA, USA.
Judy D WallDepartment of Biochemistry, University of Missouri Columbia, MO, USA.
Matthew W FieldsCenter for Biofilm Engineering, Montana State University Bozeman, MT, USA ; Department of Microbiology and Immunology, Montana State University Bozeman, MT, USA.
Aindrila MukhopadhyayPhysical Biosciences Division, Lawrence Berkeley National Laboratory Berkeley, CA, USA.
Lawrence Berkeley National Laboratory · USMontana State University · USUniversity of Missouri · USUniversity of California, Berkeley · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We surveyed the eight putative cyclic-di-GMP-modulating response regulators (RRs) in Desulfovibrio vulgaris Hildenborough that are predicted to function via two-component signaling. Using purified proteins, we examined cyclic-di-GMP (c-di-GMP) production or turnover in vitro of all eight proteins. The two RRs containing only GGDEF domains (DVU2067, DVU0636) demonstrated c-di-GMP production activity in vitro. Of the remaining proteins, three RRs with HD-GYP domains (DVU0722, DVUA0086, and DVU2933) were confirmed to be Mn(2+)-dependent phosphodiesterases (PDEs) in vitro and converted c-di-GMP to its linear form, pGpG. DVU0408, containing both c-di-GMP production (GGDEF) and degradation domains (EAL), showed c-di-GMP turnover activity in vitro also with production of pGpG. No c-di-GMP related activity could be assigned to the RR DVU0330, containing a metal-dependent phosphohydrolase HD-OD domain, or to the HD-GYP domain RR, DVU1181. Studies included examining the impact of overexpressed cyclic-di-GMP-modulating RRs in the heterologous host E. coli and led to the identification of one RR, DVU0636, with increased cellulose production. Evaluation of a transposon mutant in DVU0636 indicated that the strain was impaired in biofilm formation and demonstrated an altered carbohydrate:protein ratio relative to the D. vulgaris wild type biofilms. However, grown in liquid lactate/sulfate medium, the DVU0636 transposon mutant showed no growth impairment relative to the wild-type strain. Among the eight candidates, only the transposon disruption mutant in the DVU2067 RR presented a growth defect in liquid culture. Our results indicate that, of the two diguanylate cyclases (DGCs) that function as part of two-component signaling, DVU0636 plays an important role in biofilm formation while the function of DVU2067 has pertinence in planktonic growth.

Indexed as

biofilmcyclic-di-GMPDesulfovibrioGGDEFGGDEF-EALHD-GYPresponse regulatortwo-component system

Identifiers

PMID25120537
PMCPMC4114195
OpenAlexW2154881045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.